263 The Vanishing Fertility Doctor Dream. Drs. Kevin Maas, Cristin Slater, Kyle Tobler
Doctors used to dream not just of earning well, but of controlling how they practiced and how they cared for patients.Doctors Cristin Slater, Kevin Maas, and Kyle Tobler—partners at the independently owned Idaho Center for Reproductive Medicine—explain why that dream feels so far away for many.Here’s what we cover:Why Dr. Maas says he’d never go back to a private equity-owned networkHidden legal clauses & earn-outs that can trap REIsThe tug-of-war between business interests and clinical decisionsHow independent practices can innovate (including the tech they love)The advice they’d give to any fellow or young REI thinking about their future, and how they can still live the dream
--------
1:00:21
--------
1:00:21
262 The Pinnacle Operational Model. Pain. Progress. Payoff. Beth Zoneraich
Beth Zoneraich, CEO of Pinnacle Fertility, is back on Inside Reproductive Health to share the hard numbers and the deeper philosophy behind what she calls the Pinnacle Operational Model.We deep dive into::Why they automate the back end of patient care (but never the front)How 3,000 unanswered phone calls became 500 new patientsThe “J curve” of operational change (where things get worse before they get better)Whether business leaders can help achieve work-life balance for clinical staffThe build vs buy debateHow they saved $1M saved by building (not buying) a witnessing system
--------
51:35
--------
51:35
261 RMA-NY Gets Smart About Genetic Counseling Crunch. Teresa Cacchione
With a very limited number of genetic counselors nationwide, it’s impossible for every fertility patient to see one. Clinics like RMA New York are getting strategic.In this week’s episode of Inside Reproductive Health, genetic counselor Teresa Cacchione explains why genetic counseling in IVF is becoming increasingly critical and complex.Teresa discusses:Why and how RMA-NY relies on a partner called GeneScreen Why even low-risk carrier results can confuse patients (and what to do about it)The growing demand for informed consent around PGTThe risks of relying solely on lab panelsHow RMA decides which patients need in-house counselingThe legal and ethical implications of not providing sufficient counseling before treatment
--------
43:28
--------
43:28
260 Avoiding IVF’s Next Public Catastrophe. Dr. Tex VerMilyea & Moises Eilemberg
They were lucky.The gas to the incubator stopped flowing, but XiltriX caught the failure in time, no embryos were lost… and no headlines were made.But what happens if the next failure isn’t?In this episode, Dr. Matthew “Tex” VerMilyea of Ovation and US Fertility, and Moises Eilemberg, CEO of XiltriX North America, return to Inside Reproductive Health to ask a hard question:What would your lab do in a crisis?You’ll hear:The catastrophic loss Sweden’s biobank suffered (and what you need to learn from it)Why embryologist shortages are reshaping the IVF labWhat standardizing monitoring protocols could mean for your networkWhy Tex believes monitoring as a service is the futureThe steps to take after a public lab failure (and how to avoid needing them)How XiltriX helps fertility labs gain 24/7 visibility, rapid response alerts, and peace of mindThis isn’t about tech. It’s about protecting the future of your lab, your brand, and your patients.
--------
53:39
--------
53:39
259 IVF's Prior Authorization Hell. Dr. Ravi Gada & Manish Chhadua
What happens when managed care surges in IVF, reimbursements drop, and physicians are expected to do more work for less?Dr. Ravi Gada and Manish Chhadua are back on the show, and they don’t hold back. Dr. Gada is a partner at one of the largest independently owned practices in the United States and he and Manish co-own and operate a firm called CloudRx, In this episode, they dig into:What 70 fertility centers are doing to slash administrative costs from prior authorization chaos How medication side savings are shifting into the medical services side (and what that means for practices)Changes in the payer market and insurer preferences you need to know aboutWhy Organon and Follistim have gained so much market share in the past 5–7 yearsWhy academic fertility center ratings are shockingly low (and what private practices can learn from that)
Inside Reproductive Health is your source for information about the growing field of fertility. Inside Reproductive Health features an active blog and weekly interviews with leaders from the clinical, investment, patient relations, and pharmaceutical corners of reproductive medicine. Be sure to subscribe to our podcast and check back frequently for new content!
Brasil